Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy (Q45861399)

17 December 2017

title

Sensitivity of 5-fluorouracil-resistant cancer cells to adenovirus suicide gene therapy (English)

1 reference

17 December 2017

1 reference

Richard C

1

1 reference

17 December 2017

Duivenvoorden W

2

1 reference

17 December 2017

Bourbeau D

3

1 reference

17 December 2017

Massie B

4

1 reference

17 December 2017

Roa W

5

1 reference

17 December 2017

Yau J

6

1 reference

17 December 2017

Th'ng J

7

1 reference

17 December 2017

publication date

28 July 2006

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

14

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

57-65

1 reference

17 December 2017

Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Current progress in suicide gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

The emerging fields of suicide gene therapy and virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

The role of the bystander effect in suicide gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Resistance to 5-fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Apoptosis induction with 5-fluorocytosine/cytosine deaminase gene therapy for human malignant glioma cells mediated by adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Flavopiridol sensitivity of cancer cells isolated from ascites and pleural fluids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

inferred from DOI database lookup

7 January 2021

based on heuristic

5-fluorouracil: a pharmacological paradigm in the use of cytotoxics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700980

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700980

1 reference

17 December 2017

Dimensions Publication ID

1034192949

0 references

1 reference

17 December 2017